Covalent inhibitors deliver targeted, long‑lasting action and unlock new possibilities for challenging targets. Discover how Evotec accelerates covalent discovery with high‑throughput MS and advanced chemoproteomics to identify, map, and validate hits.

Read about seven trends that will shape the innovations, therapies, & market landscape in oncology during 2026 & beyond.

Discover why Middlesex County, New Jersey, is a strategic choice for life sciences companies, with strong talent, research depth and site readiness to support innovation, manufacturing and long-term growth.

Cell therapy developers are under pressure to accelerate safety testing without compromising quality or regulatory compliance. Download today to learn how PCR-based mycoplasma and sterility testing can replace slow culture methods, delivering faster, more flexible, and more reliable results.

As biopharma manufacturers scale biologics to commercial production, choosing the right bioreactor size can determine long-term efficiency and cost. Download this free white paper to learn why 5,000L single-use bioreactors represent the commercial sweet spot for complex biologics—balancing flexibility, capacity, and economics.

Early-stage biologics don’t have time for trial-and-error. Download the free white paper to learn how a technology-driven approach—combining AI/ML, advanced cell line development, and intensified processes—can help you reach IND and first-in-human milestones faster.